Form 4 for RTX RTX Corporation
Accepted 2025-02-06 00:00:00 ET · period of report 2025-02-05 · accession 0001225208-25-001346 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-06 | 2025-02-05 | RTX | Williams Dantaya M | EVP, Chief HR Off | D - Sale to Iss | $129.20 | -21.2K | 23.2K | -48% | -$2.74M |
| DM | 2025-02-06 | 2025-02-05 | RTX | Williams Dantaya M | EVP, Chief HR Off | M - OptEx | $77.73 | +35.2K | 58.4K | +152% | +$2.74M |
| D | 2025-02-06 | 2025-02-05 | RTX | Williams Dantaya M | EVP, Chief HR Off | S - Sale+OE | $129.23 | -14.0K | 44.4K | -24% | -$1.81M |
| DM | 2025-02-06 | 2025-02-05 | RTX | Williams Dantaya M | EVP, Chief HR Off | M - OptEx | $0.00 | -35.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-05 | D | D | 21,187 | $129.20 | 23,227.62 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-05 | M | A | 25,100 | $72.49 | 48,327.62 | D | — | — | (F1) The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share. |
| 3 | Common | Common Stock | 2025-02-05 | M | A | 10,118 | $90.73 | 58,445.62 | D | — | — | (F1) The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share. |
| 4 | Common | Common Stock | 2025-02-05 | S | D | 14,031 | $129.23 | 44,414.62 | D | — | — | (F2) The reported price is based on a weighted average of multiple same-day transactions with prices ranging from $129.20 to $129.285 per share. Full information regarding the number of shares sold at each separate price is available to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer upon request. |
| 5 | Derivative | Stock Appreciation Right | 2025-02-05 | M | D | 10,118 | $0.00 | 0 | D | $90.73 · 2023-02-04 to 2030-02-03 | 10,118 Common Stock | |
| 6 | Derivative | Stock Appreciation Right | 2025-02-05 | M | D | 25,100 | $0.00 | 0 | D | $72.49 · 2024-02-08 to 2031-02-07 | 25,100 Common Stock |